Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism 5-HT2A receptor agonists(Serotonin 2a (5-HT2a) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H14BrNO2 |
InChIKeyUKPDSUZQPXYNRP-MUWHJKNJSA-N |
CAS Registry1430328-63-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | Denmark | 22 Apr 2024 |